Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
| Sales | 814 | 590 | 1,153 | 770 | 1,046 |
| Gross Profit | 814 | 590 | 1,153 | 770 | 1,046 |
| Operating Income | 814 | 590 | 1,153 | 770 | 1,046 |
| Pre-tax Income | 814 | 590 | 1,153 | 770 | 1,046 |
| Net Income Continuous | -3,729 | -3,260 | -2,966 | -3,065 | -2,699 |
| Net Income Discontinuous | 8,211 | -2,556 | -897 | -181 | -572 |
| Net Income | $4,482 | $-5,816 | $-3,863 | $-3,246 | $-3,271 |
| EPS Basic Total Ops | 7.56 | -10.80 | -7.20 | -6.12 | -6.12 |
| EPS Basic Continuous Ops | -6.18 | -6.05 | -5.56 | -5.77 | -5.08 |
| EPS Basic Discontinuous Ops | 13.62 | -4.74 | -1.68 | -0.34 | -1.08 |
| EPS Diluted Total Ops | 7.56 | -10.80 | -7.20 | -6.12 | -6.12 |
| EPS Diluted Continuous Ops | -6.18 | -6.05 | -5.56 | -5.77 | -5.08 |
| EPS Diluted Discontinuous Ops | 13.62 | -4.74 | -1.68 | -0.34 | -1.08 |
| EBITDA(a) | $814 | $590 | $1,153 | $770 | $1,046 |